Status Approved
First Submitted Date
2020/03/30
Registered Date
2020/04/08
Last Updated Date
2021/10/18
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0004901 |
---|---|
Unique Protocol ID | 2020AS0077 |
Public/Brief Title | Comparative analysis of the clinical effectiveness for capillary blood sampling in term newborns: laser lancing device versus automatic incision device. |
Scientific Title | Comparative analysis of the clinical effectiveness for capillary blood sampling in term newborns: laser lancing device versus automatic incision device. Randomized, Non-inferiority study. |
Acronym | |
MFDS Regulated Study | No |
IND/IDE Protocol | |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | 2020AS0077 |
Approval Date | 2020-03-24 |
Institutional Review Board Name | Korea University Ansan Hospital Institutional Review Board |
Institutional Review Board Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do |
Institutional Review Board Telephone | 031-412-6514 |
Data Monitoring Committee |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Byung Min Choi |
Title | Professor |
Telephone | +82-31-412-5551 |
Affiliation | Korea University Ansan Hospital |
Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea |
Contact Person for Public Queries | |
Name | Eui Kyung Choi |
Title | professor |
Telephone | +82-31-412-5551 |
Affiliation | Korea University Ansan Hospital |
Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea |
Contact Person for Updating Information | |
Name | Eui Kyung Choi |
Title | professor |
Telephone | +82-31-412-5551 |
Affiliation | Korea University Ansan Hospital |
Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do, Republic of Korea |
4. Status
Study Site | Single | |
---|---|---|
Overall Recruitment Status | Completed | |
Date of First Enrollment | 2020-06-09 Actual | |
Target Number of Participant | 42 | |
Primary Completion Date | 2021-09-17 , Actual | |
Study Completion Date | 2021-09-17 , Actual | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Korea University Ansan Hospital | |
Recruitment Status | Completed | |
Date of First Enrollment | 2020-06-09 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Korea University Ansan Hospital |
Organization Type | Medical Institute |
Project ID |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Korea University Ansan Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | When newborn babies for blood sampling, it is widely used because it is easier and safer to collect capillary blood by placing the heel of a newborn in a "heel puncture" rather than in an artery or vein. However, not only can the heel cause pain in newborns, but it can also be a new risk factor, such as bruises and infections. The automatic incision device is widely used in Korea instead of a manual lancet in the past. An automatic incision device that automatically moves the blade back and forth, designed to reduce pain by cutting the blood vessels in the upper part of the skin and not touching the pain nerve fibers that are located deep, and to facilitate extraction that is less affected by the nurse's proficiency than the passive needle's. Recently, laser lancet device (HandyRay ®) have been marketed in Korea after obtaining a KFDA license. This is reported to have the advantages of reducing the risk and pain of secondary infections and improving the healing process of wounds, compared to the needle or blade used to collect capillary blood from the fingers in adult diabetics. Aim of our study The clinical usefulness of laser lancet device (handyRay ®) for capillary blood collection in full-term newborn babies and automated incision device are to be compared and analyzed. Therefore, we would compare and observe efficacy of blood collection, pain reactions and wound healing processes. Hypothesis There will be no difference in clinical usefulness between laser lancet device (handyRay ®) for capillary blood collection and automated incisional device. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Supportive Care |
Phase | Not applicable |
Intervention Model | Cross-over |
Blinding/Masking | Open |
Allocation | RCT |
Intervention Type | Medical Device |
Intervention Description | Groups A and B are randomly assigned to the infants who meet the selection criteria of this study before starting the study. Put notes from group A and group B in an invisible envelope and seal them so that they cannot be opened, and store them in random order. The envelopes are opened in order and assigned to groups A and B. Group A first uses laser lancet device to collect blood, and the next day, the same amount is collected using automatic incision device.The B group first uses automatic incision device to collect the same amount of blood the next day using laser lancet device. When using a laser lancet device, prepare by referring to the instructions for use. The laser adjustment phase (Level 1 through 5) is followedby the Level 2 for collecting blood. If sufficient amount of blood is not collected, repeat the puncture by Level 3. If sufficient amount is not collected, it is defined as failure. When using an automatic incision device, prepare by referring to the instructions for use. Among two types of BD Quikheel® Lancet (Infant for Preemie), start collecting blood for Infant type. If not enough blood is collected, it is defined as failure. Side effects of infant capillary blood collection typically include bleeding, pain, bruising, infection and discoloration both of which are at risk. |
Number of Arms | 2 |
Arm 1 |
Arm Label B group |
Target Number of Participant 42 |
|
Arm Type Others |
|
Arm Description The B group first uses automatic incision device to collect the same amount of blood the next day using laser lancet device. When using an automatic incision device, prepare by referring to the instructions for use. Among two types of BD Quikheel® Lancet (Infant for Preemie), start collecting blood for Infant type. If not enough blood is collected, it is defined as failure. When using a laser lancet device, prepare by referring to the instructions for use. The laser adjustment phase (Level 1 through 5) is followed by the Level 2 for collecting blood. If sufficient amount of blood is not collected, repeat the puncture by Level 3. If sufficient amount is not collected, it is defined as failure. |
|
Arm 2 |
Arm Label A group |
Target Number of Participant 42 |
|
Arm Type Others |
|
Arm Description Group A first uses laser lancet device to collect blood, and the next day, the same amount is collected using automatic incision device. When using a laser lancet device, prepare by referring to the instructions for use. The laser adjustment phase (Level 1 through 5) is followed by the Level 2 for collecting blood. If sufficient amount of blood is not collected, repeat the puncture by Level 3. If sufficient amount is not collected, it is defined as failure. When using an automatic incision device, prepare by referring to the instructions for use. Among two types of BD Quikheel® Lancet (Infant for Preemie), start collecting blood for Infant type. If not enough blood is collected, it is defined as failure. |
9. Subject Eligibility
Condition(s)/Problem(s) |
Not Applicable-Etc
Jaundice, Neonatal |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 1Day~6Month |
|
Description - Full term neonate admitted to Korea University Ansan Hospital. - When capillary blood gas analysis or bilirubin examination is required for more than two consecutive days - Clinical hemodynamic conditions have been identified to allow capillary blood to be collected with the heel sampling - If the parents of the study participants voluntarily sign the informed consent |
|
Exclusion Criteria |
- In case of an unstable hemodynamic condition, such as congenital heart disease or severe respiratory difficulty, which affects the time of capillary refill - If no blood test is required - Premature babies under 37 weeks of pregnancy |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | /Safety/Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Efficacy of blood sampling and pain score assesment |
|
Timepoint | Immediate after procedure |
|
Secondary Outcome(s) 1 | ||
Outcome | The skin damage caused by sampling |
|
Timepoint | every day after procedure |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | Yes |
---|---|
Time of Sharing | 2021. 3 |
Way of Sharing | Available on Request
(ekchoi03@korea.ac.kr) |
TOP
BOTTOM
화면 최하단으로 이동